IL1A and rheumatoid arthritis: Application of biological therapy (antibodies or soluble receptors of TNF-α, IL-1 and IL-6) represents a great progress in the therapy of RA, while biological treatment is also frequently combined with Mtx (Maini et al., 1998; Weinblatt et al., 1999).